Recent Advances in Library Synthesis to Accelerate Medicinal Chemistry Research
Learn how parallel medicinal chemistry (PMC) and high throughput experimentation (HTE) combined with machine learning can provide a more focused approach to target molecules, resulting in a more concentrated set of compounds to make the process of lead selection easier.
Our experts show how PMC can shorten the turnaround time of the design-synthesis-test cycle, providing more compounds with limited scaffolds by using streamlined workflows and accumulated parallel synthesis knowledge.
Check out our comprehensive platform of discovery chemistry services
Related Content
Tuberculosis is the leading cause of death from an infectious disease and is caused by Mycobacterium tuberculosis (MTB). Inosine-5′-monophosphate dehydrogenase...
VIEW RESOURCEMutant p53 is one of the most attractive targets for new anti-cancer drugs. Although traditionally regarded as difficult to drug,...
VIEW RESOURCE